Clinical end point acceptance limit [Study As­sess­ment]

posted by PKS – India, 2019-04-05 09:17 (937 d 03:33 ago) – Posting: # 20128
Views: 2,486

» » Should I conclude bio-equivalence with the values of [-0.2025, 0.076] in clinical end point study. Can I assume it as within the interval of (-0.20, 0.20)
»
» What does your protocol say on exactly that matter?

My protocol says within (-0.20 and 0.20)

Complete thread:

Activity
 Admin contact
21,760 posts in 4,550 threads, 1,545 registered users;
online 4 (0 registered, 4 guests [including 3 identified bots]).
Forum time: Thursday 12:50 CEST (Europe/Vienna)

Always remember that you are absolutely unique.
Just like everyone else.    Margaret Mead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5